195
Huang MT, Badmaev V, Ding Y, Liu Y, Xie JG, Ho CT (2000) Anti-tumor and anti-carcinogenic
activities of triterpenoid, beta-boswellic acid. Biofactors 13:225–230
Hwang BY, Su BN, Chai H, Mi Q, Kardono LB, Afriastini JJ, Riswan S, Santarsiero BD, Mesecar
AD, Wild R, Fairchild CR, Vite GD, Rose WC, Farnsworth NR, Cordell GA, Pezzuto JM,
Swanson SM, Kinghorn AD (2004) Silvestrol and episilvestrol, potential anticancer rocaglate
derivatives from Aglaia Silvestris. J Org Chem 69:3350–3358
Ichikawa H, Takada Y, Shishodia S, Jayaprakasam B, Nair MG, Aggarwal BB (2006) Withanolides
potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of
nuclear factor-κB (NF-κB) activation and NF-κB-regulated gene expression. Mol Cancer Ther
5(6):1434–1445
Jancinova V, Perecko T, Nosal R, Mihalova D, Bauerova K, Drabikova K (2011) Pharmacological
regulation of neutrophil activity and apoptosis: contribution to new strategy for modulation of
inflammatory processes. Interdiscip Toxicol 4:11–14
Jayaprakasam B, Zhang Y, Seeram NP, Nair MG (2003) Growth inhibition of human tumor cell
lines by withanolides from Withania somnifera leaves. Life Sci 74(1):125–132
Jena GB, Nemmani KV, Kaul CL, Ramarao P (2003) Protective effect of a polyherbal formulation (Immu-21) against cyclophosphamide-induced mutagenicity in mice. Phytother Res
17:306–310
Jing Y, Nakajo S, Xia L, Nakaya K, Fang Q, Waxman S, Han R (1999) Boswellic acid acetate
induces differentiation and apoptosis in leukemia cell lines. Leuk Res 23:43–50
John VD, Kuttan G, Krishnankutty K (2002) Anti-tumour studies of metal chelates of synthetic
curcuminoids. J Exp Clin Cancer Res 21:219–224
Joseph CD, Praveenkumar V, Kuttan G (1999) Myeloprotective effect of a non-toxic indigenous
preparation rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot
study. J Exp Clin Cancer Res 18:325–329
Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M (2005) Reactive oxygen species
promote TNFa-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649–661
Kapil A, Moza N (1992) Anticomplementary activity of boswellic acids-an inhibitor of
C3-convertase of the classical complement pathway. Int J Immunopharmacol 14:1139–1143
Karikar C, Maitra A, Bisht S, Feldmann G, Soni S, Ravi R (2007) Polymeric nanoparticleencapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy.
J Nanomater 5:3
Katiyar SK, Agarwal R, Mukhtar H (1996) Inhibition of tumor promotion in sencar mouse skin by
ethanol extract of Zingiber officinale rhizome. Cancer Res 56:1023–1030
Kikuzaki H, Nakatani N (1993) Antioxidants effects of some ginger constituents. J Food Sci
58:1407–1410
Kim M, Hagiwara N, Smith SJ, Yamamoto T, Yamane T, Takahashi T (1995) Preventive effect
of green tea polyphenols on colon carcinogenesis. In: Huang MT, Osawa T, Ho CT, Rosen
RT (eds) Food phytochemicals for cancer prevention II. Teas, spices and herbs. American
Chemical Society, Washington, DC, pp 51–55
Kleijnen J, Knipschild P (1992a) Gingko Biloba for cerebral insufficiency. Br J Clin Pharmacol
34:352–358
Kleijnen J, Knipschild P (1992b) Gingko biloba. Lancet 340:1136–1139
Kolonel LN, Altshuler D, Henderson BE (2004a) The multiethnic cohort study: exploring genes,
lifestyle and cancer risk. Nat Rev Cancer 4:519–527
Lee KH (1999) Anticancer drug design based on plant-derived natural products. J Biomed Sci
6:236–250
Li L, Ahmed B, Mehta K, Kurzrock R (2007) Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther
6:1276–1282
8 Cancer Combating Biomolecules From Plants
Précédent

- 205/442

Suivant